TABLE 7.
The diagnostic efficiency analysis of four AAD biomarkers.
| AUC | p-value | 95% CI | Sensitivity (%) | Specificity (%) | Cutoff (ng/dl) | Youden index | |
|---|---|---|---|---|---|---|---|
| LUMICAN | 0.636 | 0.004 | 0.547–0.725 | 70.1 | 57.5 | 1.865 | 0.276 |
| PI16 | 0.739 | 0.000 | 0.661–0.816 | 55.8 | 78.1 | 1.973 | 0.339 |
| FGL1 | 0.607 | 0.024 | 0.512–0.702 | 90.9 | 43.8 | 0.223 | 0.347 |
| MMP9 | 0.641 | 0.003 | 0.552–0.731 | 84.4 | 43.8 | 0.99 | 0.282 |
| PI16 + LUM | 0.742 | 0.000 | 0.665–0.819 | 90.9 | 43.8 | 0.33 | 0.347 |
| PI16 + FGL1 | 0.769 | 0.000 | 0.693–0.845 | 71.4 | 71.2 | 0.515 | 0.426 |
| LUMICAN + FGL1 | 0.653 | 0.001 | 0.565–0.741 | 59.7 | 71.2 | 0.517 | 0.309 |
| LUMICAN + FGL1 + PI16 | 0.780 | 0.000 | 0.707–0.852 | 67.5 | 76.7 | 0.675 | 0.442 |